Cargando…
Interaction between HER2 and ATM predicts poor survival in bladder cancer patients
Human Epidermal Growth Factor Receptor 2 (HER2) overexpression is considered one of the interesting prognostic biomarkers in bladder cancer. However, the mechanism of bladder cancer development in relation to HER2 status remains to be elucidated. In this study, we investigated HER2‐Ataxia telangiect...
Autores principales: | Albarakati, Nada, Al‐Shareeda, Alaa, Ramadan, Majed, Al‐Sowayan, Batla, Negm, Ola, Nedjadi, Taoufik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549494/ https://www.ncbi.nlm.nih.gov/pubmed/36056635 http://dx.doi.org/10.1111/jcmm.17512 |
Ejemplares similares
-
Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients
por: Albarakati, Nada, et al.
Publicado: (2023) -
Nanogenomics and Artificial Intelligence: A Dynamic Duo for the Fight Against Breast Cancer
por: Al-Sowayan, Batla S., et al.
Publicado: (2021) -
Stem cells and the pursuit of youth, a tale of limitless possibilities and commercial fraud
por: Al-Sowayan, Batla S, et al.
Publicado: (2021) -
Cancer Stem Cell-Exosomes, Unexposed Player in Tumorigenicity
por: Al-Sowayan, Batla S., et al.
Publicado: (2020) -
The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer
por: Albarakati, Nada, et al.
Publicado: (2019)